Sandra Ogungbemi, MD
Pulmonary Disease · Greenwood, INNPI 1548676240
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $6,657 of the $7,725 with a category attached, or 86.2%. Medical Device Business Services, Inc. accounts for 76.4% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $3,893, more than ten times the $30 reported in 2020.
Across 51 payments — averaging $151.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$6K
- Medtronic$715
- Intuitive Surgical$555
- Johnson & Johnson$268
- Pinnacle Biologics, Inc$85
- Regeneron Healthcare Solutions, Inc.$75
- plus $126 from 5 others
What the payments were for
- Travel & lodging$6,65786%
- Food & beverage$1,03813%
- Gifts$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 11 | $5,902 |
| Medtronic | 16 | $715 |
| Intuitive Surgical | 6 | $555 |
| Johnson & Johnson | 7 | $268 |
| Pinnacle Biologics, Inc | 4 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $75 |
| Merz North America, Inc. | 1 | $30 |
| Amgen | 1 | $27 |
| Boehringer Ingelheim | 1 | $26 |
| United Therapeutics Corporation | 1 | $22 |
| Precigen, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MONARCH$5,568
- Da Vinci Surgical System$488
- ILLUMISITE$427
- Monarch Platform$141
How this compares
$7,725 in reported general payments places this provider in the 70th percentile of 258 pulmonary disease providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $541 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Greenwood
- Faisal KhanGreenwood$207K
- Sandeep KukrejaGreenwood$206K
- Robert DalyGreenwood$54K
- Umar OsmanGreenwood$19K
- Imad ShawaGreenwood$11K
- David MaresAnderson$1.3M
- David WilsonSeymour$689K
- Giovanni InfusinoCrown Point$526K
- Ajay DeshpandeTerre Haute$304K
- Raja DevanathanHobart$193K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.